The role of benzodiazepines in the management of status epilepticus

Neurology

Volumn 40, Issue 5, 1990, Pages 32-42

  Treiman, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ACTION POTENTIAL; ADULT; AGED; ANIMAL; DISEASE MODEL; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HUMAN; MALE; NERVE CELL; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION; TIME;

ACTION POTENTIALS; ADULT; AGED; ANIMAL; BENZODIAZEPINES; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; HUMAN; MALE; MIDDLE AGE; NEURONS; STATUS EPILEPTICUS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; SYNAPSES; SYNAPTIC TRANSMISSION; TIME FACTORS;

EID: 0025427070     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Macdonald RL, McLean MJ. Anticonvulsant drugs: mechanisms of action. In: Delgado-Escueta AV, Ward AA Jr, Woodbury DM, Porter RJ, eds. Basic mechanisms of the epilepsies: molecular and cellular approaches. Advances in neurology, vol. 44. New York: Raven Press, 1986:713-36.
2. Randall LO, Heise GA, Schallek W, et al. Pharmacological and clinical studies on Valium: a new psychotherapeutic agent of the benzodiazepine class. Curr Ther Res 1961;3:405-425.
3. Swinyard EA, Castellion AW. Anticonwlsant properties of some benzodiazepines. J Pharmacol Exp Ther 1966;151:369-375.
4. K r d RL, Penry JK, White BG, et al. Antiepileptic drug development. I1. Anticonvulsant drug screening. Epilepsia 1978;19:409-428.
5. Skerritt JH, Werz MA, McLean MJ, Macdonald RL. Diazepam and its anomalous p-chloro-derivative Ro5-4864. Comparative effects on mouse neurons in cell culture. Brain Res 1974;310:99-105.
6. Macdonald RL, Barker JL. Benzodiazepines specifically modulate GABA-mediated postsynaptic inhibition in cultured mammalian neurones. Nature 1978;271:563-564.
7. Macdonald RL, Barker JL. Enhancement of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: a common mode of anticonvulsant action. Brain Res 1979;167:323-336.
8. Skerritt JH, Macdonald RL. Benzodiazepine Ro15-1788 electrophysiological evidence for partial agonist activity. Neurosci Lett 1983;43:321-326.
9. Skemtt JH, Macdonald RL. Diazepam enhances the action but not the binding of the GABA analog, THIP. Brain Res 1984;297:181-186.
10. Skerritt JH, Macdonald RL. Benzodiazepine receptor ligand actions on GABA responses: benzodiazepines CL 218-872, zopiclone. Eur J Pharmacol 1984;101:127-134.
11. Squires RF, Braestrup C. Benzodiazepine receptors in rat brain. Nature 1977;66:732-734.
12. Brodie BB, Reid WD. Is man a unique animal in response to drugs? Am J Pharm 1969;141:21-27.
13. Treiman DM, Walton NY, Kendrick CW. A progressive sequence of electroencephalographic changes during generalized convulsive status epilepticus. Epilepsy Res 1990;5:49-60.
14. Treiman DM, Walton NY, Wickboldt CW, DeGiorgio CM. Pre- dictable sequence of EEG changes during generalized convulsive status epilepticus in man and three experimental models of status epilepticus in the rat [Abstract]. Neurology 1987;7(suppl 1):352.
15. Lothman EW, Bertram EH, Bekenstein JW, Perlin JB. Selfsustaining limbic status epilepticus induced by “continuous” hippocampal stimulation: electrographic and behavioral characteristics. Epilepsy Res 1989;3:107-119.
16. Handforth A, Treiman DM. Electrogenic convulsive status epilepticus- a new model of generalized status [Abstract]. Epilepsia 1989;30:671.
17. Walton NY, Treiman DM. Experimental secondarily generalized convulsive status epilepticus induced by D, L-homocysteine thiolactone. Epilepsy Res 1988;2:79-86.
18. Walton NY, Treiman DM. Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice. Neurology 1990 (in press).
19. Walton NY, Treiman DM. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp Neurol 1988;101:267-275.
20. Lothman E. The biochemical basis and pathophysiology of status epilepticus. Neurology 1990;40(suppl2):13-23.
21. Walton NY, Gunawan S, Treiman DM. Brain amino acid concentration changes during status epilepticus induced by lithium and pilocarpine. Exp Neurol (in press).
22. Treiman DM. Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia 1989;30(suppl 12):S4-S10.
23. Gastaut H, Naquet R, Poire R, Tassinari CA. Treatment of status epilepticus with diazepam (Valium). Epilepsia 1965;6:167-182.
24. Naquet R, Soulayrol R, Dolce G, et al. First attempt at treatment of experimental status epilepticus in animals and spontaneous status epilepticus in man with diazepam (Valium). Electroencephalogr Clin Neurophysiol 1965;18:427.
25. Leppik IE, Derivan AT, Homan RW, et al. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 1983;249:1452-1454.
26. Treiman DM, DeGiorgio CM, Ben-Menachem E, et al. Lorazepam vs phenytoin in the treatment of generalized convulsive status epilepticus: report of an ongoing study [Abstract]. Neurology 1985;35(suppl1):284.
27. Browne T. The pharmacokinetics of agents used in the treatment of status epilepticus. Neurology 1990;40(suppl2):28-32.
28. Treiman DM. Status epilepticus. In: Johnson RT, ed. Current therapy in neurological diseases, 2nd ed. Philadelphia: B.C. Decker, 1987:38-42.
29. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology 1988;38:202-207.